Published in Nat Med on January 06, 2013
RADAR: a rigorously annotated database of A-to-I RNA editing. Nucleic Acids Res (2013) 1.88
A disrupted RNA editing balance mediated by ADARs (Adenosine DeAminases that act on RNA) in human hepatocellular carcinoma. Gut (2013) 1.80
The Genomic Landscape and Clinical Relevance of A-to-I RNA Editing in Human Cancers. Cancer Cell (2015) 1.61
ADAR1 Activation Drives Leukemia Stem Cell Self-Renewal by Impairing Let-7 Biogenesis. Cell Stem Cell (2016) 1.50
Adenosine-to-inosine RNA editing and human disease. Genome Med (2013) 1.40
Deciphering the functions and regulation of brain-enriched A-to-I RNA editing. Nat Neurosci (2013) 1.25
Principles Governing A-to-I RNA Editing in the Breast Cancer Transcriptome. Cell Rep (2015) 1.21
A-to-I editing of coding and non-coding RNAs by ADARs. Nat Rev Mol Cell Biol (2015) 1.14
The genetic and epigenetic alterations in human hepatocellular carcinoma: a recent update. Protein Cell (2014) 1.10
Genomic analysis of ADAR1 binding and its involvement in multiple RNA processing pathways. Nat Commun (2015) 0.99
Human coding RNA editing is generally nonadaptive. Proc Natl Acad Sci U S A (2014) 0.96
Integrated mRNA and microRNA transcriptome sequencing characterizes sequence variants and mRNA-microRNA regulatory network in nasopharyngeal carcinoma model systems. FEBS Open Bio (2014) 0.93
Functional and genetic deconstruction of the cellular origin in liver cancer. Nat Rev Cancer (2015) 0.92
Susceptibility loci revealed for bovine respiratory disease complex in pre-weaned holstein calves. BMC Genomics (2014) 0.91
Sequential transcriptome analysis of human liver cancer indicates late stage acquisition of malignant traits. J Hepatol (2013) 0.91
An oncogenic role of Agrin in regulating focal adhesion integrity in hepatocellular carcinoma. Nat Commun (2015) 0.91
Integration of mRNA expression profile, copy number alterations, and microRNA expression levels in breast cancer to improve grade definition. PLoS One (2014) 0.90
HBx induces hypomethylation of distal intragenic CpG islands required for active expression of developmental regulators. Proc Natl Acad Sci U S A (2014) 0.90
Structures of human ADAR2 bound to dsRNA reveal base-flipping mechanism and basis for site selectivity. Nat Struct Mol Biol (2016) 0.89
RNA editing in RHOQ promotes invasion potential in colorectal cancer. J Exp Med (2014) 0.88
Systematic identification and characterization of RNA editing in prostate tumors. PLoS One (2014) 0.88
An RNA editor, adenosine deaminase acting on double-stranded RNA (ADAR1). J Interferon Cytokine Res (2014) 0.86
Alternative applications for distinct RNA sequencing strategies. Brief Bioinform (2014) 0.85
Genetic mapping uncovers cis-regulatory landscape of RNA editing. Nat Commun (2015) 0.84
RNA editing enters the limelight in cancer. Nat Med (2013) 0.84
A Fluorescent Adenosine Analogue as a Substrate for an A-to-I RNA Editing Enzyme. Angew Chem Int Ed Engl (2015) 0.84
An RNA editing fingerprint of cancer stem cell reprogramming. J Transl Med (2015) 0.83
Somatic mutations, viral integration and epigenetic modification in the evolution of hepatitis B virus-induced hepatocellular carcinoma. Curr Genomics (2014) 0.82
Altered RNA editing in 3' UTR perturbs microRNA-mediated regulation of oncogenes and tumor-suppressors. Sci Rep (2016) 0.82
Gene amplification-associated overexpression of the RNA editing enzyme ADAR1 enhances human lung tumorigenesis. Oncogene (2015) 0.81
New Insights into the Biological Role of Mammalian ADARs; the RNA Editing Proteins. Biomolecules (2015) 0.81
Novel interaction of ornithine decarboxylase with sepiapterin reductase regulates neuroblastoma cell proliferation. J Mol Biol (2013) 0.80
Rapid and dynamic transcriptome regulation by RNA editing and RNA modifications. J Cell Biol (2016) 0.80
Detection of canonical A-to-G editing events at 3' UTRs and microRNA target sites in human lungs using next-generation sequencing. Oncotarget (2015) 0.79
Identification of human RNA editing sites: A historical perspective. Methods (2016) 0.78
Structural basis of antizyme-mediated regulation of polyamine homeostasis. Proc Natl Acad Sci U S A (2015) 0.78
Harnessing human ADAR2 for RNA repair - Recoding a PINK1 mutation rescues mitophagy. Nucleic Acids Res (2016) 0.78
RefSeq curation and annotation of antizyme and antizyme inhibitor genes in vertebrates. Nucleic Acids Res (2015) 0.78
RNA Editing Modulates Human Hepatic Aryl Hydrocarbon Receptor Expression by Creating MicroRNA Recognition Sequence. J Biol Chem (2015) 0.78
LNCediting: a database for functional effects of RNA editing in lncRNAs. Nucleic Acids Res (2016) 0.77
RNA editing in cancer: Mechanistic, prognostic, and therapeutic implications. Mol Cell Oncol (2015) 0.77
REDIportal: a comprehensive database of A-to-I RNA editing events in humans. Nucleic Acids Res (2016) 0.77
Positive correlation between ADAR expression and its targets suggests a complex regulation mediated by RNA editing in the human brain. RNA Biol (2014) 0.77
The dynamic epitranscriptome: A to I editing modulates genetic information. Chromosoma (2015) 0.77
A meta-analysis of multiple matched copy number and transcriptomics data sets for inferring gene regulatory relationships. PLoS One (2014) 0.77
RBP-Var: a database of functional variants involved in regulation mediated by RNA-binding proteins. Nucleic Acids Res (2015) 0.76
An efficient system for selectively altering genetic information within mRNAs. Nucleic Acids Res (2016) 0.76
Inconsistency and features of single nucleotide variants detected in whole exome sequencing versus transcriptome sequencing: A case study in lung cancer. Methods (2015) 0.76
Multifaceted interactions and regulation between antizyme and its interacting proteins cyclin D1, ornithine decarboxylase and antizyme inhibitor. Oncotarget (2015) 0.76
Liver cancer oncogenomics: opportunities and dilemmas for clinical applications. Hepat Oncol (2015) 0.75
RNA editing generates cellular subsets with diverse sequence within populations. Nat Commun (2016) 0.75
Aberrant overexpression of ADAR1 promotes gastric cancer progression by activating mTOR/p70S6K signaling. Oncotarget (2016) 0.75
RED: A Java-MySQL Software for Identifying and Visualizing RNA Editing Sites Using Rule-Based and Statistical Filters. PLoS One (2016) 0.75
Evidence for multiple, distinct ADAR-containing complexes in Xenopus laevis. RNA (2014) 0.75
RNA Editing Dynamically Rewrites the Cancer Code. Trends Cancer (2015) 0.75
RNA editing-dependent epitranscriptome diversity in cancer stem cells. Nat Rev Cancer (2017) 0.75
Antizyme inhibitor 1: a potential carcinogenic molecule. Cancer Sci (2016) 0.75
Characterization of RNA editome in primary and metastatic lung adenocarcinomas. Oncotarget (2017) 0.75
Regulation of Human Endonuclease V Activity and Relocalization to Cytoplasmic Stress Granules. J Biol Chem (2016) 0.75
Single-cell RNA sequencing reveals dynamic changes in A-to-I RNA editome during early human embryogenesis. BMC Genomics (2016) 0.75
Regulatory factors governing adenosine-to-inosine (A-to-I) RNA editing. Biosci Rep (2015) 0.75
ADAR1 overexpression is associated with cervical cancer progression and angiogenesis. Diagn Pathol (2017) 0.75
Recoding RNA editing of AZIN1 is oncogenic in hepatocellular carcinoma. Cancer Discov (2013) 0.75
RNA editing and drug discovery for cancer therapy. ScientificWorldJournal (2013) 0.75
RNA editing as an activator of self-renewal in cancer. Stem Cell Investig (2016) 0.75
Applying Human ADAR1p110 and ADAR1p150 for Site-Directed RNA Editing-G/C Substitution Stabilizes GuideRNAs against Editing. Genes (Basel) (2017) 0.75
Discriminative Prediction of A-To-I RNA Editing Events from DNA Sequence. PLoS One (2016) 0.75
Systematic characterization of A-to-I RNA editing hotspots in microRNAs across human cancers. Genome Res (2017) 0.75
Massive A-to-I RNA editing is common across the Metazoa and correlates with dsRNA abundance. Genome Biol (2017) 0.75
Oncogenic Activation of the RNA Binding Protein NELFE and MYC Signaling in Hepatocellular Carcinoma. Cancer Cell (2017) 0.75
Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol (2009) 235.12
Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics (2009) 190.94
Global cancer statistics, 2002. CA Cancer J Clin (2005) 119.22
TopHat: discovering splice junctions with RNA-Seq. Bioinformatics (2009) 81.13
Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol (2010) 75.21
RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet (2009) 58.77
The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer (2002) 28.11
Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution. Nature (2009) 18.08
VarScan: variant detection in massively parallel sequencing of individual and pooled samples. Bioinformatics (2009) 16.04
Principles of CDK regulation. Nature (1995) 13.09
Antiviral actions of interferons. Clin Microbiol Rev (2001) 13.06
Advances in understanding cancer genomes through second-generation sequencing. Nat Rev Genet (2010) 10.15
Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer (2006) 10.05
RNA editing by adenosine deaminases that act on RNA. Annu Rev Biochem (2001) 9.66
Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet (2002) 7.67
Genome-wide identification of human RNA editing sites by parallel DNA capturing and sequencing. Science (2009) 6.96
Applications of next-generation sequencing technologies in functional genomics. Genomics (2008) 6.50
RNA editing of AMPA receptor subunit GluR-B: a base-paired intron-exon structure determines position and efficiency. Cell (1993) 5.62
Autoregulatory frameshifting in decoding mammalian ornithine decarboxylase antizyme. Cell (1995) 3.64
Underediting of glutamate receptor GluR-B mRNA in malignant gliomas. Proc Natl Acad Sci U S A (2001) 3.14
A cell cycle-dependent internal ribosome entry site. Mol Cell (2000) 2.91
Deregulated expression of E2F family members induces S-phase entry and overcomes p16INK4A-mediated growth suppression. Mol Cell Biol (1996) 2.44
Altered adenosine-to-inosine RNA editing in human cancer. Genome Res (2007) 2.38
Molecular diversity through RNA editing: a balancing act. Trends Genet (2010) 1.98
Association of Vimentin overexpression and hepatocellular carcinoma metastasis. Oncogene (2004) 1.94
Q/R site editing in kainate receptor GluR5 and GluR6 pre-mRNAs requires distant intronic sequences. Proc Natl Acad Sci U S A (1996) 1.92
Polyamines regulate the expression of ornithine decarboxylase antizyme in vitro by inducing ribosomal frame-shifting. Proc Natl Acad Sci U S A (1994) 1.74
UCSC genome browser tutorial. Genomics (2008) 1.73
Down-regulation of RNA editing in pediatric astrocytomas: ADAR2 editing activity inhibits cell migration and proliferation. J Biol Chem (2008) 1.71
RNA editing, DNA recoding and the evolution of human cognition. Trends Neurosci (2008) 1.70
Molecular determinants and guided evolution of species-specific RNA editing. Nature (2005) 1.66
Antizyme targets cyclin D1 for degradation. A novel mechanism for cell growth repression. J Biol Chem (2004) 1.58
Predicting conformational switches in proteins. Protein Sci (1999) 1.38
A macromolecular inhibitor of the antizyme to ornithine decarboxylase. Biochem J (1982) 1.37
A-to-I RNA editing and cancer: from pathology to basic science. RNA Biol (2008) 1.32
RNA editing: a driving force for adaptive evolution? Bioessays (2009) 1.19
Sub-lethal radiation enhances anti-tumor immunotherapy in a transgenic mouse model of pancreatic cancer. BMC Cancer (2002) 1.14
Antizyme and antizyme inhibitor, a regulatory tango. Cell Mol Life Sci (2009) 1.12
Antizyme inhibitor: mysterious modulator of cell proliferation. Cell Mol Life Sci (2006) 1.09
Crystallographic and biochemical studies revealing the structural basis for antizyme inhibitor function. Protein Sci (2008) 1.06
Degradation of antizyme inhibitor, an ornithine decarboxylase homologous protein, is ubiquitin-dependent and is inhibited by antizyme. J Biol Chem (2004) 1.03
Evidence of a role for antizyme and antizyme inhibitor as regulators of human cancer. Mol Cancer Res (2011) 1.00
Antizyme, a mediator of ubiquitin-independent proteasomal degradation and its inhibitor localize to centrosomes and modulate centriole amplification. Oncogene (2007) 0.98
EGFR mutation and resistance of non-small-cell lung cancer to gefitinib. N Engl J Med (2005) 26.35
Topological domains in mammalian genomes identified by analysis of chromatin interactions. Nature (2012) 18.23
The Genome sequence of the SARS-associated coronavirus. Science (2003) 16.68
The genetic landscape of a cell. Science (2010) 16.52
Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA (2003) 16.08
Genome-wide association study of 107 phenotypes in Arabidopsis thaliana inbred lines. Nature (2010) 10.66
Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature (2007) 10.40
RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science (2009) 9.29
Oncofetal gene SALL4 in aggressive hepatocellular carcinoma. N Engl J Med (2013) 7.48
Modelling schizophrenia using human induced pluripotent stem cells. Nature (2011) 7.41
A distinct lineage of influenza A virus from bats. Proc Natl Acad Sci U S A (2012) 6.27
MicroRNA expression, survival, and response to interferon in liver cancer. N Engl J Med (2009) 6.13
Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology (2007) 5.75
Trends in survival after in-hospital cardiac arrest. N Engl J Med (2012) 5.67
Characterization of human metapneumoviruses isolated from patients in North America. J Infect Dis (2002) 5.64
Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning. Nat Med (2003) 5.45
The oyster genome reveals stress adaptation and complexity of shell formation. Nature (2012) 5.30
Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet (2007) 5.21
A high-resolution map of the three-dimensional chromatin interactome in human cells. Nature (2013) 5.18
Yersinia YopJ acetylates and inhibits kinase activation by blocking phosphorylation. Science (2006) 4.71
A Francisella tularensis pathogenicity island required for intramacrophage growth. J Bacteriol (2004) 4.67
Temporal dynamics of the human vaginal microbiota. Sci Transl Med (2012) 4.58
BIM mediates EGFR tyrosine kinase inhibitor-induced apoptosis in lung cancers with oncogenic EGFR mutations. PLoS Med (2007) 4.50
Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1. Nat Genet (2004) 4.45
Synthetic genetic array analysis in Saccharomyces cerevisiae. Methods Mol Biol (2006) 4.45
Human illness from avian influenza H7N3, British Columbia. Emerg Infect Dis (2004) 4.29
Transcription factors in myeloid development: balancing differentiation with transformation. Nat Rev Immunol (2007) 4.27
Real-time observation on dynamic growth/dissolution of conductive filaments in oxide-electrolyte-based ReRAM. Adv Mater (2012) 4.23
Differential effects of gefitinib and cetuximab on non-small-cell lung cancers bearing epidermal growth factor receptor mutations. J Natl Cancer Inst (2005) 4.19
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial. Ann Surg Oncol (2011) 4.16
New world bats harbor diverse influenza A viruses. PLoS Pathog (2013) 4.10
Increased exonic de novo mutation rate in individuals with schizophrenia. Nat Genet (2011) 4.01
Hematopoietic stem cell and multilineage defects generated by constitutive beta-catenin activation. Nat Immunol (2006) 3.98
Heterozygous PU.1 mutations are associated with acute myeloid leukemia. Blood (2002) 3.97
Evaluation of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina: results from the TERISA randomized clinical trial (Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina). J Am Coll Cardiol (2013) 3.90
Erk associates with and primes GSK-3beta for its inactivation resulting in upregulation of beta-catenin. Mol Cell (2005) 3.89
Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada. PLoS Med (2010) 3.85
Long-term outcomes in elderly survivors of in-hospital cardiac arrest. N Engl J Med (2013) 3.85
Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C/EBP alpha. Immunity (2004) 3.84
Deletion of vascular endothelial growth factor in myeloid cells accelerates tumorigenesis. Nature (2008) 3.82
Epigenomic analysis of multilineage differentiation of human embryonic stem cells. Cell (2013) 3.81
Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival via the Akt/PKB pathway. Cancer Cell (2004) 3.63
Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung. Nat Biotechnol (2007) 3.54
C/EBPbeta is required for 'emergency' granulopoiesis. Nat Immunol (2006) 3.53
Regulation of Notch1 and Dll4 by vascular endothelial growth factor in arterial endothelial cells: implications for modulating arteriogenesis and angiogenesis. Mol Cell Biol (2003) 3.51
Genetic variants and risk of lung cancer in never smokers: a genome-wide association study. Lancet Oncol (2010) 3.49
Meta-analysis of traditional Chinese patent medicine for ischemic stroke. Stroke (2007) 3.46
AMPylation of Rho GTPases by Vibrio VopS disrupts effector binding and downstream signaling. Science (2008) 3.44
Ambulatory arterial stiffness index as a predictor of cardiovascular mortality in the Dublin Outcome Study. Hypertension (2006) 3.42
Human Bocavirus infection, Canada. Emerg Infect Dis (2006) 3.30
Pre-existing AAV capsid-specific CD8+ T cells are unable to eliminate AAV-transduced hepatocytes. Mol Ther (2007) 3.26
Fully room-temperature-fabricated nonvolatile resistive memory for ultrafast and high-density memory application. Nano Lett (2009) 3.24
Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy. Nature (2004) 3.24
A Pseudomonas syringae effector inactivates MAPKs to suppress PAMP-induced immunity in plants. Cell Host Microbe (2007) 3.15
Induction of tumor angiogenesis by Slit-Robo signaling and inhibition of cancer growth by blocking Robo activity. Cancer Cell (2003) 3.14
The scale of population structure in Arabidopsis thaliana. PLoS Genet (2010) 3.12
PINK1 phosphorylates ubiquitin to activate Parkin E3 ubiquitin ligase activity. J Cell Biol (2014) 3.12
Long-term survival analysis of pure laparoscopic versus open hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a single-center experience. Ann Surg (2013) 3.11
Inactivating E2f1 reverts apoptosis resistance and cancer sensitivity in Trp53-deficient mice. Nat Cell Biol (2003) 3.05
Triple reassortant H3N2 influenza A viruses, Canada, 2005. Emerg Infect Dis (2006) 3.05
Label-free, normalized quantification of complex mass spectrometry data for proteomic analysis. Nat Biotechnol (2009) 3.01
Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26. Nature (2013) 3.00
Complete sequencing of pNDM-HK encoding NDM-1 carbapenemase from a multidrug-resistant Escherichia coli strain isolated in Hong Kong. PLoS One (2011) 2.98
Identification of a novel astrovirus (astrovirus VA1) associated with an outbreak of acute gastroenteritis. J Virol (2009) 2.96
Insulin storage and glucose homeostasis in mice null for the granule zinc transporter ZnT8 and studies of the type 2 diabetes-associated variants. Diabetes (2009) 2.92
Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis. Lancet Oncol (2012) 2.91
Novel avian influenza H7N3 strain outbreak, British Columbia. Emerg Infect Dis (2004) 2.90
Masked hypertension in diabetes mellitus: treatment implications for clinical practice. Hypertension (2013) 2.89
Plasmon-induced transparency in metamaterials. Phys Rev Lett (2008) 2.88
miR-130b Promotes CD133(+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1. Cell Stem Cell (2010) 2.87
Modeling of C/EBPalpha mutant acute myeloid leukemia reveals a common expression signature of committed myeloid leukemia-initiating cells. Cancer Cell (2008) 2.87
Pseudomonas syringae effector AvrPto blocks innate immunity by targeting receptor kinases. Curr Biol (2007) 2.84
Nf1-dependent tumors require a microenvironment containing Nf1+/-- and c-kit-dependent bone marrow. Cell (2008) 2.84
Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations. Mol Cancer Res (2008) 2.82
Distinct gene expression profiles of acute myeloid/T-lymphoid leukemia with silenced CEBPA and mutations in NOTCH1. Blood (2007) 2.77
Anterior chamber width measurement by high-speed optical coherence tomography. Ophthalmology (2005) 2.77
An alternative inhibitor overcomes resistance caused by a mutation of the epidermal growth factor receptor. Cancer Res (2005) 2.72
Susceptibility to neurodegeneration in a glaucoma is modified by Bax gene dosage. PLoS Genet (2005) 2.68
An Epstein-Barr virus-encoded microRNA targets PUMA to promote host cell survival. J Exp Med (2008) 2.68
Progressive ganglion cell loss and optic nerve degeneration in DBA/2J mice is variable and asymmetric. BMC Neurosci (2006) 2.68
Distinctive and indispensable roles of PU.1 in maintenance of hematopoietic stem cells and their differentiation. Blood (2005) 2.64
Prognostic value of reading-to-reading blood pressure variability over 24 hours in 8938 subjects from 11 populations. Hypertension (2010) 2.64
Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer. Nat Med (2010) 2.62
The order of expression of transcription factors directs hierarchical specification of hematopoietic lineages. Genes Dev (2006) 2.62
Clinical and molecular characterisation of hereditary dopamine transporter deficiency syndrome: an observational cohort and experimental study. Lancet Neurol (2010) 2.60
Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation. Nat Biotechnol (2004) 2.60
Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007. J Infect Dis (2009) 2.59
Anterior approach versus conventional approach right hepatic resection for large hepatocellular carcinoma: a prospective randomized controlled study. Ann Surg (2006) 2.59
Developmental checkpoints of the basophil/mast cell lineages in adult murine hematopoiesis. Proc Natl Acad Sci U S A (2005) 2.59
A decade's studies on metastasis of hepatocellular carcinoma. J Cancer Res Clin Oncol (2003) 2.50
Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009. BMJ (2011) 2.50
Correlation of IHC and FISH for ALK gene rearrangement in non-small cell lung carcinoma: IHC score algorithm for FISH. J Thorac Oncol (2011) 2.50